

Multiple studies now suggest a strong correlation between vascular endothelial growth factor (VEGF) expression and poor prognosis in colorectal cancer. In one analysis, Ishigami and colleagues collected tissue from 60 patients with primary colorectal cancer, noting the ratio of VEGF mRNA in tumorous vs nontumorous tissue (defined as VEGF T/N ratio). Patients with high VEGF T/N ratios demonstrated significantly poorer survival.5

A 2006 meta-analysis by Des Guetz and colleagues confirms that vascular endothelial growth factor (VEGF) expression is associated with poor overall survival in colorectal cancer. The researchers analyzed numerous studies of angiogenesis in colorectal cancer, including 27 studies specifically investigating VEGF in this disease setting. In this meta-analysis, VEGF expression was shown to be significantly correlated with poor overall survival and was a stronger predictor of overall survival than microvessel density.2
Ishigami SI, Arii S, Furutani M, et al. Br J Cancer. 1998;78:1379-1384.
Des Guetz G, Uzzan B, Nicolas P, et al. Br J Cancer. 2006;94:1823-1832.